Drug Trial Radar · NCT06170476
A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONV
Last checked: Nov 20, 2026Latest source record: Jul 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Nov 10, 2023
Primary completion
Feb 28, 2024
Study completion May 15, 2024
Sponsor
- Lead sponsor
- Sichuan Provincial People's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 14, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled Dose-Finding study. About 200 subjects undergoing elective laparoscopic abdominal or gynecological surgery are planned to be enrolled and randomized into four groups by a ratio of 1:1:1:1.
Conditions
- Postoperative Nausea and Vomiting
Interventions
HSK21542-60μgDrug
HSK21542 injection of 60 μg was administered once within 15 min before the end of surgery, and was administered by intravenous bolus injection for no less than 30 s;
HSK21542-120μgDrug
HSK21542 injection of 120 μg was administered once within 15 min before the end of surgery, and was administered by intravenous bolus injection for no less than 30 s;
HSK21542-180μgDrug
HSK21542 injection of 180 μg was administered once within 15 min before the end of surgery, and was administered by intravenous bolus injection for no less than 30 s;
PlaceboDrug
A placebo was administered once within 15 min before the end of surgery, and was administered by intravenous bolus injection for no less than 30 s;
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete responseTime frame: 24 hours after the end of surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial People's Hospital
Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.